Quinapril NDC 69097-842

NDC codes

FDA NDC Directory

Product NDC (as listed)69097-842Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69097-0842Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69097-842-05	69097084205	90 TABLET in 1 BOTTLE (69097-842-05)Marketed from Jul 22, 2016
69097-842-15	69097084215	1000 TABLET in 1 BOTTLE (69097-842-15)Marketed from Jul 22, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Quinapril
Generic name (nonproprietary): quinapril
Active ingredients: Quinapril hydrochloride — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Cipla USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078457
Marketing start: Jul 22, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)
Identifiers: Product ID 69097-842_56ce107f-65d9-4ec8-8859-6a256b27dc57SPL ID 56ce107f-65d9-4ec8-8859-6a256b27dc57SPL set ID e6d36e1e-8e35-4d06-83dc-45e0456365fdRxCUI 312748, 312749, 312750, 314203UNII 33067B3N2MUPC 0369097841058, 0369097839055, 0369097842055, 0369097843052
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469097084205 followed by a unit qualifier and the quantity

Package 69097-0842-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 19, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Hypertension Quinapril is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with quinapril. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking ce…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 078457

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078457
Product	Strength	Form · route	Labeler	Product NDC
Quinapril	Quinapril hydrochloride 5 mg/1	TabletOral	Cipla USA Inc.	69097-839
Quinapril	Quinapril hydrochloride 10 mg/1	TabletOral	Cipla USA Inc.	69097-841
Quinapril	Quinapril hydrochloride 40 mg/1	TabletOral	Cipla USA Inc.	69097-843
Quinapril	Quinapril hydrochloride 10 mg/1	TabletOral	Proficient Rx LP	63187-425